Sara Bobak
Psychiatry · Ann Arbor, MINPI 1073634523
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 574 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 16.9% — the pattern of someone who eats at a lot of different presentations. Among psychiatry clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 574 payments — averaging $23.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Neurocrine Biosciences, Inc.$2K
- Johnson & Johnson$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$997
- Takeda Pharmaceuticals U.S.A., Inc.$922
- Lundbeck LLC$577
- plus $5K from 28 others
What the payments were for
- Food & beverage$13,194100%
- Education$300%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 108 | $2,239 |
| Neurocrine Biosciences, Inc. | 63 | $1,833 |
| Johnson & Johnson | 83 | $1,818 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 46 | $997 |
| Takeda Pharmaceuticals U.S.A., Inc. | 47 | $922 |
| Lundbeck LLC | 27 | $577 |
| Axsome Therapeutics, Inc. | 16 | $575 |
| Vanda Pharmaceuticals Inc. | 20 | $572 |
| Otsuka America Pharmaceutical, Inc. | 20 | $457 |
| Ironshore Pharmaceuticals Inc. | 18 | $385 |
| Corium, LLC | 15 | $365 |
| Tris Pharma Inc | 18 | $311 |
| Supernus Pharmaceuticals, Inc. | 11 | $267 |
| Almatica Pharma LLC | 12 | $258 |
| Noven Therapeutics, LLC | 10 | $222 |
| Bausch Health US, LLC | 9 | $186 |
| Idorsia Pharmaceuticals US Inc | 8 | $146 |
| Jazz Pharmaceuticals Inc. | 6 | $134 |
| Alkermes, Inc. | 1 | $126 |
| Eisai Inc. | 1 | $116 |
| Collegium Pharmaceutical, Inc. | 5 | $107 |
| Teva Pharmaceuticals USA, Inc. | 3 | $82 |
| Neuronetics, Inc. | 4 | $79 |
| OWP Pharmaceuticals, Inc. | 3 | $72 |
| Shire North American Group Inc | 5 | $71 |
| Sunovion Pharmaceuticals Inc. | 3 | $59 |
| Merck | 3 | $54 |
| Harmony Biosciences LLC | 1 | $45 |
| Neos Therapeutics, LP | 2 | $37 |
| Adlon Therapeutics L.p. | 2 | $32 |
| Arbor Pharmaceuticals, Inc. | 1 | $24 |
| Livanova USA, Inc. | 1 | $22 |
| Novo Nordisk | 1 | $21 |
| Alfasigma USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,224 in reported general payments places this provider in the 95th percentile of 1,166 psychiatry providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lamotrigine | 11 | $89 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Ann Arbor
- Sagar ParikhAnn Arbor$83K
- Rajaprabhakaran RajarethinamAnn Arbor$29K
- Juan LopezAnn Arbor$21K
- Andreas SidiropoulasDetroit$2.8M
- Welton WashingtonYpsilanti$1.4M
- Joel YoungRochester Hills$1.1M
- Manzar RajputMonroe$612K
- William GuySouthfield$562K
- Robert LagrouClarkston$267K
- Michael IngramBay City$255K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.